Replies to post #56096 on Titan Medical Inc (TMDIF)

[66Mustang]

Those scenarios certainly do exist hypothetically!

I think the only real driving force behind split ratio selection is to ensure the end PPS is sufficient for the uplisting with a bit of a buffer to cover any price fluctuations. I don't have any specific preference for a higher or lower ratio because the math will still work out the same; I will own a certain percentage of the market cap value.

The game here will be minimizing dilution, which cuts our percentages down. I wish I could personally do something about that. I do wonder if they could have priced the offering a couple cents higher; two cents more per share would mean 18% less dilution to raise the same funds, and we were around .16 or so when the announcement came out. It could have possibly served to stabilize the PPS around .13 instead of around .11 for the near term. But then again, I also did take advantage of this buy opportunity; I got more at .1122 so I can't complain. And management may have needed to pick a price which assures they successfully raise the money they need. Must have been yet another tough decision!

[SPORT19]

I think the best way to look at value is by looking at market cap, currently $18.7m. That is so ridiculous IMO that unless they just close up shop this has nowhere to go but up. Looking at everything that goes into creating a general surgery robotic platform, $, time, patents, R&D etc, market potential and the market cap of competitors TRXC an ISRG I believe we should have a market cap today of at least $100m but I think closer to $150m. Assuming we sell all the units in this offering a market cap of 100m would be .29 and 150m would be .44.
On the question of how high this can go organically again think of MC. At $1 PPS and 342m OS that's a MC of $342m, which is a stretch for the foreseeable future barring a partnership. This is how I look at it.